TNRG NEWS!!
Tianrong Begins Filing Process With FDA for Electrocardiograph
SAN FRANCISCO, Feb. 23 /PRNewswire/ -- Tianrong Building Material Holdings, Ltd. (OTC Bulletin Board: TNRG) today announced that its medical division has started the filing process for its advanced personal computer based electrocardiograph (PC-ECG). The first step in the process, which has now been completed by TNGR, was to file an initial registration for its device with the FDA. The company anticipates completion of the filing process and FDA approval by the end of June.
The battery powered PC-ECG will provide a reliable means to display, record and store a patient's ECG signal through a personal computer. The collected data can be used to aid physicians in their diagnosis and treatment of cardiovascular diseases. It can be used in physicians' offices, research laboratories, gyms and emergency vehicles. Because of its portability and affordability, it can be prescribed by doctors for patients as a home monitoring device.
According to the Department of Health & Human Services cardiovascular diseases (CVD) are the leading cause of death and illness in the United States. Fifty-eight million Americans suffer from one or more types of CVD. The estimated cost of CVD in the United States in 1998 alone was $274 billion.
James Tilton, president of TNRG, stated "One of the exciting factors involved with a diversified company such as TNRG is the many different products that we review and take to market. Currently, our Chinese and Internet divisions are drawing significant focus. This focus can certainly be justified given the huge revenue generating potential of the divisions but our medical division should not be ignored. It also has major revenue generating potential and unlike tobacco producers, that face multibillion dollar lawsuits, our medical division offers products that help fight the human battle against diseases. I am personally proud that such products are going to be available because of the efforts of our people at TNRG."
Tianrong is a business development company that has set as its goal the acquisition of businesses in numerous industries and plans to apply Tianrong's management expertise to quickly grow value in the acquired businesses. Tianrong has announced future stock dividends in three subsidiaries and on a long-term basis may elect to issue stock dividends in other subsidiaries.
For further information contact investor relations at 800-641-5844 or visit www.tnrg.com.
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including, without limitation, the ability of Tianrong Building Material Holdings to accomplish its stated plan of business. Tianrong Building Material Holdings believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and, therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by Tianrong Building Material Holdings or any other person that the objectives and plans of Tianrong Building Material Holdings will be achieved.
SOURCE Tianrong Building Material Holdings, Ltd.
CO: Tianrong Building Material Holdings, Ltd.
ST: New York
IN: CST HEA
SU:
02/23/99 13:31 EST prnewswire.com |
